JODI HAMEL: Open Payments
NPI 1962958553 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,447 in 186 payments from 24 companies in 2025. Trend: 2023 $3,714 · 2024 $3,114 · 2025 $3,447
Food & beverage: $3,447
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $532 |
| ABBVIE INC. | 29 | $509 |
| Novo Nordisk Inc | 18 | $362 |
| Lilly USA, LLC | 12 | $251 |
| PFIZER INC. | 17 | $249 |
| GlaxoSmithKline, LLC. | 11 | $211 |
| Otsuka America Pharmaceutical, Inc. | 15 | $177 |
| Exact Sciences Corporation | 8 | $167 |
| Amgen Inc. | 11 | $162 |
| Axsome Therapeutics, Inc. | 9 | $141 |
Products named: REXULTI, QULIPTA, AIRSUPRA, NURTEC ODT, Ozempic, BREZTRI, FARXIGA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
